{
    "nct_id": "NCT06736054",
    "official_title": "A Phase I Trial of 61Cu-NODAGA-PSMA for Patients with Prostate Cancer",
    "inclusion_criteria": "1. Biopsy proven prostate adenocarcinoma\n2. Age ≥ 18 years\n3. ECOG 0 or 1\n4. At least one site of PSMA-positive disease on a PSMA-targeted PET/CT performed within 30 days of trial recruitment\n5. Creatinine of ≤1.4 or Creatinine Clearance or ≥ 60 mL/minute.\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "1. Known allergy/hypersensitivity to PSMA-targeted imaging agents\n2. Other active malignancy, other than the known prostate cancer",
    "miscellaneous_criteria": ""
}